x

Posted 24 June, 2021

INTEGRA LIFESCIENCES HOLDINGS CORP appointed new CEO

CEO Change detected for ticker Nasdaq:IART in a 8-K filed on 24 June, 2021.


  (b) On June 22, 2021, Peter J. Arduini informed Integra LifeSciences Holdings Corporation (the "Company") of his intention to resign from his position as President and Chief Executive Officer and director of the Company in order to accept an executive position with another company.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of INTEGRA LIFESCIENCES HOLDINGS CORP
Health Care/Life Sciences • Medical Equipment/Supplies
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Market Cap
$2.87B
View Company Details
INTEGRA LIFESCIENCES HOLDINGS CORP by TradingView
Relevant filing section
ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


(b) On June 22, 2021, Peter J. Arduini informed Integra LifeSciences Holdings Corporation (the "Company") of his intention to resign from his position as President and Chief Executive Officer and director of the Company in order to accept an executive position with another company. Mr. Arduini's resignation will be effective December 31, 2021. 


A copy of the press release announcing the resignation of Mr. Arduini is attached to this report as Exhibit 99.1.